Christopher Drinjak

Christopher specialises in assisting lawyers to enhance their skills, win new instructions, manage client relationships and augment their international networks.

He has worked in senior business development roles based in the UK and in Germany, and currently is the business development lead for the firm's Life Sciences & Healthcare industry sector.

CV

Since 2019 Senior business development manager (Life sciences and healthcare), and Senior business development manager (Disputes and investigations, IP, Commercial tech and data, and Patents), Taylor Wessing

2011 - 2018 Senior practice development manager, Industry development (Global financial institutions group), and Interim head of business development Germany, Latham & Watkins

2001 - 2011 Business development manager (Finance and capital markets), Head of London L&DR business development, and Business development manager (Litigation and dispute resolution), Clifford Chance

Carrière

2011 - 2018 Senior practice development manager, Industry development (Global financial institutions group), and Interim head of business development Germany, Latham & Watkins

2001 - 2011 Business development manager (Finance and capital markets), Head of London L&DR business development, and Business development manager (Litigation and dispute resolution), Clifford Chance

Formation

2001 Masters of business administration, International University, Germany

1996 M.A. in musicology, Michigan State University, US

1994 B.A. in German and B.A. in Music Performance, Michigan State University, US

Christopher Drinjak

Expertise

Secteurs

CV

Carrière

Formation

Langues étrangères

Christopher Drinjak

Expertise

Secteurs

CV

Carrière

Formation

Langues étrangères

Related news & insights

Biotechnology as a security issue: Why dual-use control and adaptive regulation are crucial for national sustainability

Advertising skinny jabs – regulators react

Reform of the Veterinary Medicines Act

Once daily, twice defeated in Ireland

Politics of European countries protecting the supply of critical medicines medical devices

EU and medicines supply issues (part one): Current measures

Kim Wedral new Cambridge partner announcement

EU and medicines supply issues (part two): Proposals for future measures

Guidance to manufacturers withdrawing a medical device from the EU market

Comparison of national measures to protect the supply of medicines and medical devices

Autres avocats qui pourraient vous intéresser

Rendez-vous à